Found "Public health policy": 1,033 results
Sort by
Z - A

Vietnam Country Visit

( 11- 16 November 2013) Health Intervention and Technology Assessment Program (HITAP) researchers and the program leader, Dr. Yot Teerwattananon, made a scoping visit to Vietnam in November 2013. The purpose of the scoping visit was to evaluate the current status of Health Technology Assessment (HTA

Vast F.D.A. Effort Tracked E-Mails of Its Scientists

WASHINGTON — A wide-ranging surveillance operation by the Food and Drug Administration against a group of its own scientists used an enemies list of sorts as it secretly captured thousands of e-mails that the disgruntled scientists sent privately to members of Congress, lawyers, labor officials, jou

Variation of health-related quality of life assessed by caregivers and patients affected by severe childhood infections. (2013)

Variation of health-related quality of life assessed by caregivers and patients affected by severe childhood infections. Wantanee KulpengEmail author, Vorasith Sornsrivichai, Virasakdi Chongsuvivatwong, Waranya Rattanavipapong, Pattara Leelahavarong, John Cairns, Yoel Lubell and Yot Teerawattanan

Value Driven Outcomes – allowing the cabins to talk to one another so the boat sails smoothly

BackgroundRecently the Saw Swee Hock School of Public Health (SSHSPH) at the National University of Singapore (NUS) held the Leadership Development Programme (LDP) with primary focus on advancing universal health coverage (UHC) through the use of HTA. And Prof Kishore Mahbubani, who is the Senior Ad

Value Distribution in New Branded Medicines: How Much Benefits Patients Versus Manufacturers?

Thailand has successfully implemented economic evaluation to inform the inclusion of new, branded medicines within its National List of Essential Medicines (NLEM). This method can be used to assess the health value that new medicines will generate for patients after accounting for the health los

Vaccinology for Clinical and Public Health Practice: Policy Symposium and Workshop: From participant’s perspective

This blog has been jointly written by Dr. Phetsavanh Chanthavilay from the Institute of Research and Education Development, University of Health Sciences, Lao PDR, and Mr. Nantasit Luangasanatip from the Mahidol-Oxford Tropical Medicine Research Unit, Thailand. Their participation in this e

Vaccinology course – Ghana

This virtual workshop was provided for public health professionals, researchers, and policy makers from Ghana, Malawi, and Tanzania. The course covered topics such as political economy of vaccinology, vaccine policy and distribution, and the science of vaccines, with a specific focus on the COVID-19 pandemic and COVID-19 vaccines.

Vaccination program in a resource-limited setting: A case study in the Philippines

Objective: Implementing national-level vaccination programs involves long-term investment, which can be a significant financial burden, particularly in resource-limited settings. Although many studies have assessed the economic impacts of providing vaccinations, evidence on the positive and negative

Utilisation of evidence from Thailand’s National Health Examination Survey in policy development: finding the weakest link

Abstract Background Health surveillance and survey data are helpful in evidence-informed policy decisions. This study is part of an evaluation of the National Health Examination Survey (NHES) programme in Thailand. This paper focuses on the obstacles in the translation of survey information into

Using HTA to inform R&D: The Case of Total Systems Effectiveness

How do decision-makers in Thailand decide whether a new or improved vaccine should be added to the Expanded Program on Immunization (EPI)?What is the vaccine prioritization and selection processes in Thailand?How can the product preferences of low and middle-income countries (LMICS) be better commun
10 / Page